Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 16:65:102295.
doi: 10.1016/j.amsu.2021.102295. eCollection 2021 May.

Utility of post mastectomy radiotherapy among patients with T1/ T2 N1 disease: A retrospective cohort study

Lubna M Vohra  1 , Rufina Soomro  2 , Dua Jabeen  3 , Nasir Ali  4 , Nargis Khan  5
Affiliations

Utility of post mastectomy radiotherapy among patients with T1/ T2 N1 disease: A retrospective cohort study

Lubna M Vohra et al. Ann Med Surg (Lond). .

Abstract

Background: Pakistan has the highest incidence of breast cancer among Asian Countries but there is insufficient representation of local data addressing breast cancer treatment and outcome. We sought to determine the role of post-mastectomy radiotherapy (PMRT) in T1- T2 breast cancer with 1-3 positive axillary lymph nodes.

Methods: Data was reviewed retrospectively of total 755 patients out of which 291 received PMRT and 464 did not from two large breast cancer centres.

Results: With a median follow up of 78 months, 4 (4.5%) patients developed loco regional recurrence (LRR) in the PMRT group while a substantial number 74 (24.4%) recurred in the non PMRT group (p = 0.000). Loco regional free survival rate (LRFS) and overall survival rate (OS) was significantly better for PMRT patients than non-PMRT patients (P = <0.000). Multivariate analysis identified young age, lymphovascular invasion, extra capsular extension, triple negative and ER/PR negative were independent prognostic factors affecting loco regional free survival (LRFS).

Conclusion: Disease recurrence is a substantial issue in 1-3 node group despite early stage, PMRT has an instrumental effect in improving LRFS and OS.

Keywords: Breast cancer; Lymph nodes; Mastectomy; Patients; Radiotherapy; Recurrence; Survival.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Over Survival with and without Post mastectomy radiotherapy.
Fig. 2
Fig. 2
Disease Free Survival with and without Post mastectomy radiotherapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Harris J.R., Halpin-Murphy P., McNeese M., Mendenhall N.P., Morrow M., Robert N.J. Consensus statement on postmastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1999;44(5):989–990. doi: 10.1016/s0360-3016(99)00096-6. - DOI - PubMed
    1. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans V. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–2106. doi: 10.1016/S0140-6736(05)67887-7. - DOI - PubMed
    1. He Z.Y., Wu S.G., Zhou J., Li F.Y., Lin Q., Lin H.X. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes. PloS One. 2015;10(3) doi: 10.1371/journal.pone.0119105. e0119105. - DOI - PMC - PubMed
    1. Kaššák F., Rossier C., Picardi C., Bernier J. Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes - past, present and future. Breast. 2019;48:73–81. doi: 10.1016/j.breast.2019.09.008. - DOI - PubMed
    1. Balic M., Thomssen C., Würstlein R., Gnant M., Harbeck N. St. Gallen/vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment. Breast Care. 2019;14(2):103–110. doi: 10.1159/000499931. - DOI - PMC - PubMed